Women were less than half of the people tested for almost all of these common medicines.

NCT00922636

A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

See it on ClinicalTrials.gov β†—

340 people

100 womenmiddle line = equal numbers240 men
Phase
PHASE2, PHASE3
Paid for by
Eli Lilly and Company
Finished
2010-12
Health conditions
Attention Deficit Hyperactivity Disorder
Who could join
Anyone
Ages
6 Years – 17 Years
Average age
mean 11.63 years
Age 65+
Not reported
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
White 72.6% Β· Black / African American 13.2% Β· More than one race 7.9% Β· Asian 5% Β· American Indian / Alaska Native 1.2% Β· Native Hawaiian / Pacific Islander 0% Β· Not reported 0%

Women left out

  • Age limit under 65

    Older women were turned away, even though they often take this medicine.

    β€œMaximum age: 17 Years.”
  • No pregnant women

    Women who were pregnant could not join.

    β€œFemale patients who are pregnant or who are breast-feeding. Patients who have a history of Bipolar I/ II, psychosis, or pervasive developmental disorder.”
  • No breastfeeding moms

    Women who were breastfeeding could not join.

    β€œFemale patients who are pregnant or who are breast-feeding. Patients who have a history of Bipolar I/ II, psychosis, or pervasive developmental disorder.”
  • Had to use birth control

    Women who couldn't or didn't want to use birth control were turned away.

    β€œPatients of child-bearing potential agree to use a reliable method of birth control during the study and for 1 month following the last dose of study drug. Female patients of child-bearing potential must test negative for pregnancy at the t…”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    β€œPatients with problems that would be exacerbated by increased norepinephrine tone, including a history of cardiovascular disease, thyroid dysfunction, glaucoma, urinary retention, or severe gastrointestinal narrowing.”
  • No seizures

    Women with epilepsy or past seizures were turned away.

    β€œPatients with a history of any seizure disorder, known electroencephalographic (EEG) abnormalities in the absence of seizures.”
  • No mental health conditions

    Women with depression, bipolar disorder or other mental health conditions were turned away.

    β€œFemale patients who are pregnant or who are breast-feeding. Patients who have a history of Bipolar I/ II, psychosis, or pervasive developmental disorder.”

Study titles and rules are shown in their original English.